Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SRDX | Common Stock | Award | $0 | +2.14K | +7.08% | $0.00 | 32.3K | Feb 9, 2023 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SRDX | Stock Option (right to buy) | Award | $0 | +5.04K | $0.00 | 5.04K | Feb 9, 2023 | Common Stock | 5.04K | $28.98 | Direct | F2 |
Id | Content |
---|---|
F1 | The amount beneficially owned includes 15,342 restricted stock units (RSUs) that vest on service-based vesting dates that will be settled in shares of the issuer's common stock on a 1 for 1 basis when the reporting person's service as a director ends. |
F2 | The stock options vest ratably on a monthly basis and become fully vested on February 9, 2024, the 12-month anniversary of the grant date. |